ELTP - Elite Pharmaceuticals GAAP EPS of $0.00 revenue of $9.25M February, 14 2023 05:13 PM Elite Pharmaceuticals Inc. Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q3 GAAP EPS of $0.00. Revenue of $9.25M (+3.1% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $9.25M